Ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infection
Aim: to analyze the effectiveness of intravenous ozone therapy in long COVID-19 patients experienced community-acquired polysegmental pneumonia (associated with SARS-CoV2 infection). Materials and methods. The study involved 42 long COVID-19 individuals aged 41–82 years who underwent rehabilitati...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN RU UK |
Publicado: |
Zaporozhye State Medical University
2021
|
Materias: | |
Acceso en línea: | https://doi.org/10.14739/2310-1210.2021.6.233891 https://doaj.org/article/17137e2bcd9242af96e785f7628b162e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:17137e2bcd9242af96e785f7628b162e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:17137e2bcd9242af96e785f7628b162e2021-11-04T09:24:27ZOzone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infectionhttps://doi.org/10.14739/2310-1210.2021.6.2338912306-41452310-1210https://doaj.org/article/17137e2bcd9242af96e785f7628b162e2021-11-01T00:00:00Zhttp://zmj.zsmu.edu.ua/article/view/233891/241651https://doaj.org/toc/2306-4145https://doaj.org/toc/2310-1210Aim: to analyze the effectiveness of intravenous ozone therapy in long COVID-19 patients experienced community-acquired polysegmental pneumonia (associated with SARS-CoV2 infection). Materials and methods. The study involved 42 long COVID-19 individuals aged 41–82 years who underwent rehabilitation after community-acquired polysegmental pneumonia associated with SARS-CoV2 infection. The patients were examined and followed up subjectively (by the G. Borg and PCFS scales) and objectively (oxygen saturation, C-reactive protein, ferritin, D-dimer, urea and creatinine, 6-minute walk test). All patients received similar medicamentous therapy, and combined intravenous ozone therapy was additionally prescribed to the main group patients (n = 21): an alternate-day infusion of 200 ml ozonized saline at a concentration of 20 mg/ml and major autohemotherapy (100 ml ozonized saline at a concentration of 30 mg/ml mixed with 100 ml of the patient’s blood), 10 sessions per treatment course. Results. The integrated approach to the complex program of long COVID-19 treatment and rehabilitation for patients after pneumonia associated with SARS-CoV2 infection using intravenous ozone therapy has demonstrated its significant effectiveness based on the objective and subjective findings (P < 0.01). Twice as many patients in the main group (n = 18) achieved endpoints of the study (absence of dyspnea, normalization of blood biochemical markers and oxygen saturation levels, restoration of exercise tolerance) as compared to the control group (n = 9). Conclusions. The use of combined intravenous ozone therapy (alternating infusion of ozonized saline and ozonized saline mixed with the patient’s blood) in the rehabilitation program for patients after experienced community-acquired polysegmental pneumonia associated with SARS-CoV2 infection is pathogenetically substantiated, effective and cost-effective addition to complex health recovery tools. I. B. BaranovaA. F. GumeniukA. I. SemenenkoI. A. IliukI. P. OsypenkoZaporozhye State Medical Universityarticlerehabilitationozonotherapypneumonia viralsars-cov2 infectionlong-term covid-19MedicineRENRUUKZaporožskij Medicinskij Žurnal, Vol 23, Iss 6, Pp 752-758 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN RU UK |
topic |
rehabilitation ozonotherapy pneumonia viral sars-cov2 infection long-term covid-19 Medicine R |
spellingShingle |
rehabilitation ozonotherapy pneumonia viral sars-cov2 infection long-term covid-19 Medicine R I. B. Baranova A. F. Gumeniuk A. I. Semenenko I. A. Iliuk I. P. Osypenko Ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infection |
description |
Aim: to analyze the effectiveness of intravenous ozone therapy in long COVID-19 patients experienced community-acquired polysegmental pneumonia (associated with SARS-CoV2 infection).
Materials and methods. The study involved 42 long COVID-19 individuals aged 41–82 years who underwent rehabilitation after community-acquired polysegmental pneumonia associated with SARS-CoV2 infection. The patients were examined and followed up subjectively (by the G. Borg and PCFS scales) and objectively (oxygen saturation, C-reactive protein, ferritin, D-dimer, urea and creatinine, 6-minute walk test).
All patients received similar medicamentous therapy, and combined intravenous ozone therapy was additionally prescribed to the main group patients (n = 21): an alternate-day infusion of 200 ml ozonized saline at a concentration of 20 mg/ml and major autohemotherapy (100 ml ozonized saline at a concentration of 30 mg/ml mixed with 100 ml of the patient’s blood), 10 sessions per treatment course.
Results. The integrated approach to the complex program of long COVID-19 treatment and rehabilitation for patients after pneumonia associated with SARS-CoV2 infection using intravenous ozone therapy has demonstrated its significant effectiveness based on the objective and subjective findings (P < 0.01).
Twice as many patients in the main group (n = 18) achieved endpoints of the study (absence of dyspnea, normalization of blood biochemical markers and oxygen saturation levels, restoration of exercise tolerance) as compared to the control group (n = 9).
Conclusions. The use of combined intravenous ozone therapy (alternating infusion of ozonized saline and ozonized saline mixed with the patient’s blood) in the rehabilitation program for patients after experienced community-acquired polysegmental pneumonia associated with SARS-CoV2 infection is pathogenetically substantiated, effective and cost-effective addition to complex health recovery tools.
|
format |
article |
author |
I. B. Baranova A. F. Gumeniuk A. I. Semenenko I. A. Iliuk I. P. Osypenko |
author_facet |
I. B. Baranova A. F. Gumeniuk A. I. Semenenko I. A. Iliuk I. P. Osypenko |
author_sort |
I. B. Baranova |
title |
Ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infection |
title_short |
Ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infection |
title_full |
Ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infection |
title_fullStr |
Ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infection |
title_full_unstemmed |
Ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with SARS-CoV2 infection |
title_sort |
ozone therapy as a component of a comprehensive rehabilitation program for patients after polysegmental pneumonia associated with sars-cov2 infection |
publisher |
Zaporozhye State Medical University |
publishDate |
2021 |
url |
https://doi.org/10.14739/2310-1210.2021.6.233891 https://doaj.org/article/17137e2bcd9242af96e785f7628b162e |
work_keys_str_mv |
AT ibbaranova ozonetherapyasacomponentofacomprehensiverehabilitationprogramforpatientsafterpolysegmentalpneumoniaassociatedwithsarscov2infection AT afgumeniuk ozonetherapyasacomponentofacomprehensiverehabilitationprogramforpatientsafterpolysegmentalpneumoniaassociatedwithsarscov2infection AT aisemenenko ozonetherapyasacomponentofacomprehensiverehabilitationprogramforpatientsafterpolysegmentalpneumoniaassociatedwithsarscov2infection AT iailiuk ozonetherapyasacomponentofacomprehensiverehabilitationprogramforpatientsafterpolysegmentalpneumoniaassociatedwithsarscov2infection AT iposypenko ozonetherapyasacomponentofacomprehensiverehabilitationprogramforpatientsafterpolysegmentalpneumoniaassociatedwithsarscov2infection |
_version_ |
1718444945158701056 |